Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
Conditions
Interventions
Intervention1: Tamsulosin Solifenacin and Mirabegron Silodosin: All Patients undergoing DJ Stent placement will be randomized into two groups (1:1) by a computer generated randomization
Group A p
Sponsors
AIIMS Bathinda
Eligibility
Inclusion criteria
Inclusion criteria: 1.All patients who will be undergoing Double J ureteral stent placement during ureterscopic removal of stone 2.All patients who will be undergoing Double J ureteral stent placement during Percutaneous nephrolithotomy 3.Age 18 years to 60 years of all genders consenting for study
Exclusion criteria
Exclusion criteria: 1.Patients who are already prescribed any of drugs which are being studied in this research either in monotherapy or in combination (tamsulosin, mirabegron, solifenacin or silodosin) 2.Patients who had residual stone fragments after surgical intervention 3.Patients underwent bilateral double J stent placement. 4.Pregnant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Endpoint: Mean USSQ score at six weeks Timepoint: six weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Endpoints: a) Mean USSQ score at one week b) Mean USSQ score at 3 weeks Timepoint: ONE WEEK THREE WEEKS | — |
Countries
India
Contacts
Public ContactDr Abhishek chhabra
AIIMS BATHINDA
Outcome results
None listed